title: Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.
authors.affiliation: Department of Surgery, University of Wisconsin School of Medicine, Madison.
authors.forename: R J
authors.initials: RJ
authors.lastname: Stratta
authors.forename: A M
authors.initials: AM
authors.lastname: D'Alessandro
authors.forename: M J
authors.initials: MJ
authors.lastname: Armbrust
authors.forename: J D
authors.initials: JD
authors.lastname: Pirsch
authors.forename: H W
authors.initials: HW
authors.lastname: Sollinger
authors.forename: M
authors.initials: M
authors.lastname: Kalayoglu
authors.forename: F O
authors.initials: FO
authors.lastname: Belzer
mesh_terms: D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000627:therapeutic use*; D003929:Diabetic Neuropathies / Q000601:surgery; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use*; D011379:Prognosis; D011897:Random Allocation; D014184:Transplantation, Homologous
chemical_list: D000961:Antilymphocyte Serum; D003524:Cyclosporins; D001379:Azathioprine; D011241:Prednisone; D008775:Methylprednisolone